S100A9 + CD14 + monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellula...
S100A9 + CD14 + monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function
About this item
Full title
Author / Creator
Tu, Xiaoxuan , Chen, Longxian , Zheng, Yi , Mu, Chenglin , Zhang, Zhiwei , Wang, Feiyu , Ren, Yiqing , Duan, Yingxin , Zhang, Hangyu , Tong, Zhou , Liu, Lulu , Sun, Xunqi , Zhao, Peng , Wang, Lie , Feng, Xinhua , Fang, Weijia and Liu, Xia
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
The paucity of reliable biomarkers for predicting immunotherapy efficacy in patients with advanced hepatocellular carcinoma (HCC) has emerged as a burgeoning concern with the expanding use of immunotherapy. This study endeavors to delve into the potential peripheral biomarkers capable of prognosticating efficacy in HCC patients who are poised to re...
Alternative Titles
Full title
S100A9 + CD14 + monocytes contribute to anti-PD-1 immunotherapy resistance in advanced hepatocellular carcinoma by attenuating T cell-mediated antitumor function
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_51d8672f00fb48fbb243daddc542d21b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_51d8672f00fb48fbb243daddc542d21b
Other Identifiers
ISSN
1756-9966,0392-9078
E-ISSN
1756-9966
DOI
10.1186/s13046-024-02985-1
